F+FreeMedSite USMLELearn with clinical reasoning
SEPARATE VIVA EXTENSION

MEN1 and the three principal endocrine tumor groups

Follow-up oral questions and concise, clinically defensible model answers. Your MCQ remains open in its original tab.

← Return to original MCQ
EXAMINER FOLLOW-UP 1

What is a frequent early MEN1 manifestation?

Primary hyperparathyroidism, often involving multiple parathyroid glands.

EXAMINER FOLLOW-UP 2

Which pancreatic tumor causes fasting hypoglycemia?

An insulinoma.

EXAMINER FOLLOW-UP 3

What general genetic model explains tumor initiation in MEN1 carriers?

A germline tumor-suppressor defect plus somatic loss of the remaining functional allele.